Cost-effectiveness evaluation of compliance therapy for people with psychosis
- 1 May 1998
- journal article
- clinical trial
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 172 (5) , 420-424
- https://doi.org/10.1192/bjp.172.5.420
Abstract
Background: Non-compliance rates with antipsychotic medication can be high, and the personal and societal costs are considerable. A new psychological intervention, compliance therapy seeks to improve compliance and patient outcomes and reduce treatment costs.Method: A randomised controlled study examined the cost-effectiveness of compliance therapy compared to nonspecific counselling over 18 months for 74 people with psychosis admitted as inpatients at the Maudsley Hospital. Bivariate and multivariate analyses were conducted to test for differences and to explore inter-patient cost variations.Results: Compliance therapy is more effective and is no more expensive. Consequently, compliance therapy is more cost-effective than non-specific counselling at six, 12 and 18 months.Conclusions: There are compliance, outcome and cost-effectiveness arguments in favour of compliance therapy in preference to non-specific counselling.Keywords
This publication has 10 references indexed in Scilit:
- Randomised controlled trial of compliance therapyThe British Journal of Psychiatry, 1998
- Compliance Therapy: An Intervention Targeting Insight and Treatment Adherence in Psychotic PatientsBehavioural and Cognitive Psychotherapy, 1996
- Compliance therapy in psychotic patients: randomised controlled trialBMJ, 1996
- Cost of Relapse in SchizophreniaSchizophrenia Bulletin, 1995
- Medication Self-Management: A preliminary report on an intervention to improve medication complianceJournal of Mental Health, 1995
- Will the new antipsychotics improve the treatment of schizophrenia?BMJ, 1993
- Insight and PsychosisThe British Journal of Psychiatry, 1990
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validityPsychological Medicine, 1983
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970